Can a Stick-On sensor replace fingersticks after heart surgery?

NCT ID NCT06338748

Completed Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checked how well the Dexcom G7, a continuous glucose monitor worn on the skin, matches standard blood sugar tests in 28 adults recovering from heart surgery. Researchers compared readings from the sensor to those from blood draws and fingerstick tests. The goal was to see if the Dexcom G7 could be a reliable, less painful alternative for monitoring glucose in the intensive care unit and regular hospital floors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexcom G7 continuous glucose monitor (device)
What this could lead to: If successful, this could show that the Dexcom G7 is a reliable, less invasive way to track glucose after heart surgery, reducing the need for frequent fingersticks.
What could go wrong: This is a small, completed study with only 28 participants, so results may not apply to all patients. The device was used in blinded mode, so it did not guide treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTINUOUS GLUCOSE MONITORING

Contacts and locations

Locations

The Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.